| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 130,876 | 123,194 | 102,572 | 120,840 | | Cost of Revenue | 44,432 | 39,413 | 36,803 | 41,890 | | | Gross Profit | 86,444 | 83,781 | 65,769 | 78,950 | | | Operating Expenses | | Research Development | 35,823 | 36,383 | 38,628 | 40,649 | | Selling General and Administrative | 19,743 | 22,222 | 21,889 | 21,578 | | Non Recurring | 175 | 303 | 335 | 39 | | Others | 9,836 | 9,836 | 9,836 | 9,836 | | | | Total Operating Expenses | 65,577 | 68,744 | 70,688 | 72,102 | | | | Operating Income or Loss | 20,867 | 15,037 | (4,919) | 6,848 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,144) | (2,917) | 3,482 | 17,501 | | Earnings Before Interest And Taxes | 17,584 | 12,120 | (1,437) | 24,349 | | Interest Expense | (1,652) | 841 | 811 | 3,234 | | Income Before Tax | 19,236 | 11,279 | (2,248) | 21,115 | | Income Tax Expense | (8,583) | 3,430 | 1,669 | 7,428 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 27,669 | 7,849 | (3,917) | 13,687 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,819 | 7,849 | (3,917) | 13,687 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $27,819 | $7,849 | ($3,917) | $13,687 |
|
0.01% Nasdaq 
0.52%
Income Statement
